Value Based Procurement | Global Developments and Australia's Next Steps
As healthcare systems face increasing demand, workforce pressures and budget constraints, there is growing interest in procurement approaches that look beyond product price alone to consider patient outcomes, pathway efficiency and total cost of care.
Join MTAA and international value-based procurement expert Brian Mangan, CEO of Luach Consulting Group and former NHS Supply Chain value-based procurement leader, for an insightful discussion on the latest developments emerging from the United Kingdom's NHS and their relevance to the Australian healthcare market.
The webinar will explore the foundations of Value-Based Procurement (VBP), recent NHS initiatives and lessons from implementation, while also examining Australia's own VBP journey.
Participants will gain a practical understanding of how health systems are defining and measuring value, how procurement decisions are increasingly considering outcomes across the patient pathway, and what MedTech companies can do to better articulate, evidence and demonstrate value to healthcare customers.
Who should attend?
- Market access and reimbursement
- Government affairs and policy
- Commercial and business development
- Tender and procurement teams
- Health economics and outcomes research
- Clinical and medical affairs
Event Details
- Date: Tuesday 1 December 2026
- Time: 5:00pm - 6:00pm AEDT
Register via the link below.
Please note: This webinar will be recorded and may be shared in the future at the discretion of the MTAA and that by registering for this event you agree to MTAA's Terms and Conditions and MTAA's Privacy Policy.
Contact Information
Additional Information
Your Speakers
Brian is a recognised expert in Value-Based Procurement and healthcare procurement, with more than 20 years’ experience across the NHS and international healthcare markets. As the architect of the first at-scale Value-Based Procurement programme across the English NHS, delivered through NHS Supply Chain, he brings first-hand experience of how value-based approaches can be embedded into real-world procurement. Brian has presented and consulted across the UK, Ireland, Australia, New Zealand, South Africa, Portugal, Slovenia, and further afield, and works with clients ranging from SMEs entering the NHS market to commercial teams at some of the world’s largest medtech organisations. For MTAA members, Brian offers a valuable buyer-side perspective on how health systems assess value, build procurement business cases and translate clinical, economic and patient outcomes into purchasing decisions. His international experience working with medtech companies and health systems also provides practical lessons for suppliers navigating the shift from traditional price-based procurement toward value and outcomes-based models.
Pravin Siriwardena is Senior Manager, Policy at the Medical Technology Association of Australia (MTAA), leading policy and advocacy initiatives across environmental, social and governance (ESG), procurement, and industry development. With extensive experience engaging government, healthcare providers and industry leaders, he works to advance policy reforms that support a sustainable, innovative and resilient MedTech sector. Pravin, on behalf of the Australian MedTech industry, has led national industry policy engagement on sustainable healthcare, modern slavery, battery stewardship, circular economy and medical plastics policy. He represents Australia on the Global Medical Technology Alliance (GMTA) Sustainability Committee and is an industry partner on the Solving Plastic Waste Cooperative Research Centre (CRC). In procurement, Pravin has spearheaded MTAA’s policy and advocacy with Australian state health procurement agencies to improve procurement frameworks, contracting practices and market access pathways. He regularly presents on the intersection of sustainability, procurement and innovation, helping organisations develop awareness and capability to engage on ESG policy developments while ensuring suppliers can continue to deliver outcomes for patients and the health system.
